SRPT -- are you concerned that their revenues just got hacked in as much as half, accelerating their already high cash burn rate leaving them with only a few months left of cash, running out probably Q1 2013?
I find it somewhat interesting that the drug data news they issued within 5 minutes of the PR saying a huge portion of their government funding got cut off. They only had around 9 months of cash left BEFORE that bad news. IMO a secondary is in the works which isn't necessarily a bad thing for stocks outside of the biotech industry but within the biotech industry they often get slaughtered on the secondary news especially when they're up so much already.
